1 recruiting, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
Follow Serina Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAD Study in Patients With Parkinson's Disease and Motor Fluctuations SER-252 (PEOZ-apomorphine), enFuse - PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease | Phase 1 | Recruiting | Serina Therapeutics | 40 | 2026-02-01 | 2026-06-05 |
| A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214 SER-214 - Parkinson's Disease | Phase 1 | Unknown | Serina Therapeutics | 20 | 2016-01-01 | 2023-04-11 |
United States (2) · Australia (1)